The collective findings indicate that mesothelin markedly upregulates the transcription of Sdha, a constituent of mitochondrial complex II, thereby enhancing mitochondrial respiration and the expression of genes encoding glycolytic pathway-associated enzymes in AML cells. The gene discussed is SDHA; the disease is acute myeloid leukemia.